MMP-2 Regulates Erk1/2 Phosphorylation and Aortic Dilatation in Marfan Syndrome

被引:97
|
作者
Xiong, Wanfen [1 ]
Meisinger, Trevor [1 ]
Knispel, Rebecca [1 ]
Worth, Jennifer M. [1 ]
Baxter, B. Timothy [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA
基金
美国国家卫生研究院;
关键词
aortic aneurysms; doxycycline; losartan; Marfan syndrome; matrix metalloproteinases; transforming growth factor-beta; BETA-BLOCKER THERAPY; TGF-BETA; MOUSE MODEL; TUMOR INVASION; IN-VITRO; ANEURYSM; PATHOGENESIS; TETRACYCLINE; DOXYCYCLINE; ACTIVATION;
D O I
10.1161/CIRCRESAHA.112.268268
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Aneurysm and dissection of the ascending thoracic aorta are the main cardiovascular complications of Marfan syndrome (MFS) resulting in premature death. Studies using mouse models of MFS have shown that activation of transforming growth factor-beta (TGF-beta) and the concomitant upregulation of matrix metalloproteinases (MMPs) contribute to aneurysm development. Our previous study showed that doxycycline delayed aneurysm rupture in a mouse model of MFS, Fbn1(mgR/mgR). Losartan has been shown to prevent aneurysms in another mouse model of MFS, Fbn1(C1039G/+), through inhibition of the Erk1/2 pathway. However, the role of MMP-2 in MFS and effect of losartan on the lifespan of MFS mice remain unknown. Objective: We investigated the role of MMP-2 in MFS and compared the effects of losartan and doxycycline on aortic dilatation and survival in Fbn1(mgR/mgR) mice. Methods and Results: By life table analysis, we found that losartan and doxycycline improved the survival of Fbn1(mgR/mgR) mice. Gelatin zymography and Western blot data showed that only doxycycline inhibited MMP-2 expression, whereas both drugs decreased Erk1/2 phosphorylation. When combined, only one of nine mice died within the 30-week study; aortic histology and diameter were normalized and the effects on Smad2 phosphorylation was additive. To further explore the role of MMP-2 in MFS, we created MMP-2-deficient Fbn1(mgR/mgR) mice. MMP-2 deletion inhibited activation of TGF-beta and phosphorylation of Erk1/2 and Smad2 and prolonged the lifespan of the mice. Conclusions: These studies demonstrated that inhibition of MMP-2 by doxycycline delayed the manifestations of MFS, in part, through its ability to decrease active TGF-beta and the noncanonical signaling cascade downstream of TGF-beta. This study further suggested that targeting TGF-beta signaling at different points might be a more effective strategy for inhibiting disease progression. (Circ Res. 2012; 110:e92-e101.)
引用
收藏
页码:E92 / E101
页数:10
相关论文
共 50 条
  • [1] Cholesterol depletion induces ANTXR2-dependent activation of MMP-2 via ERK1/2 phosphorylation in neuroglioma U251 cell
    Zou, Jianwen
    Xu, Li
    Ju, Ying
    Zhang, Peili
    Wang, Yong
    Zhang, Bingchang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 452 (01) : 186 - 190
  • [2] Mxi2 sustains ERK1/2 phosphorylation in the nucleus by preventing ERK1/2 binding to phosphatases
    Casar, Berta
    Rodriguez, Javier
    Gibor, Gilad
    Seger, Rony
    Crespo, Piero
    BIOCHEMICAL JOURNAL, 2012, 441 : 571 - 578
  • [3] Characterization of a novel ERK1/2 inhibitor, which modulates the phosphorylation and catalytic activity of ERK1/2
    Munck, Joanne M.
    Berdini, Valerio
    Bevan, Luke D.
    Braithwaite, Hannah
    Buck, Ildiko M.
    Cassidy, Megan
    Castro, Juan
    Courtin, Aurelie
    Day, James E.
    East, Charlotte
    Fazal, Lynsey
    Graham, Brent
    Griffiths-Jones, Charlotte M.
    Heightman, Tom D.
    Hindley, Chris J.
    Kidane, Birikiti
    Kucia-Tran, Justyna
    Lyons, John F.
    Martins, Vanessa
    Muench, Sandra
    Murray, Chris W.
    Norton, David
    O'Reilly, Marc
    Palmer, Nick
    Pathuri, Puja
    Reader, Mike
    Rees, David C.
    Rich, Sharna J.
    Richardson, Caroline J.
    Saini, Harpreet K.
    Shah, Alpesh
    Stanczuk, Lukas
    Thompson, Neil T.
    Walton, Hugh
    Wilsher, Nicola E.
    Woolford, Alison J.
    Wallis, Nicola G.
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [4] Erk1/2 regulates MMP production in JEG-3 cell culture.
    Andrassy, JC
    Leco, KJ
    Yang, KP
    Watson, AJ
    BIOLOGY OF REPRODUCTION, 2004, : 206 - 206
  • [5] SPRY4 regulates ERK1/2 phosphorylation to affect oxidative stress and steroidogenesis in polycystic ovary syndrome
    Pan, Yu
    Yang, Chunxia
    Sun, Yan
    Zhang, Shenmin
    Xue, Tongmin
    Li, Feng
    Fu, Dan
    STEROIDS, 2024, 212
  • [6] Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells
    Cheng, Yi-Chang
    Chen, Li-Mien
    Chang, Mu-Hsin
    Chen, Wei-Kung
    Tsai, Fuu-Jen
    Tsai, Chang-Hai
    Lai, Tung-Yuan
    Kuo, Wei-Wen
    Huang, Chih-Yang
    Liu, Chung-Jung
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 325 (1-2) : 15 - 23
  • [7] Reduced ERK1/2 and AP-1 Activity Contribute to Aortic Dilatation in Patients With Bicuspid Aortic Valve Disease
    Tobin, Stephanie W.
    Wu, Jie
    Li, Shu-Hong
    Guo, Jian
    Yeganeh, Azadeh
    Tsang, Katherine
    Tumiati, Laura
    Rocha, Rodolfo
    Butany, Jagdish
    Yau, Terrence M.
    Ouzounian, Maral
    David, Tirone E.
    Weisel, Richard D.
    Li, Ren-Ke
    CIRCULATION, 2017, 136
  • [8] Lipopolysaccharide upregulates uPA, MMP-2 and MMP-9 via ERK1/2 signaling in H9c2 cardiomyoblast cells
    Yi-Chang Cheng
    Li-Mien Chen
    Mu-Hsin Chang
    Wei-Kung Chen
    Fuu-Jen Tsai
    Chang-Hai Tsai
    Tung-Yuan Lai
    Wei-Wen Kuo
    Chih-Yang Huang
    Chung-Jung Liu
    Molecular and Cellular Biochemistry, 2009, 325 : 15 - 23
  • [9] Effects of ERK1/2 S-nitrosylation on ERK1/2 phosphorylation and cell survival in glioma cells
    Jin, Lei
    Cao, Yujia
    Zhang, Tong
    Wang, Peng
    Ji, Daofei
    Liu, Xuejiao
    Shi, Hengliang
    Hua, Lei
    Yu, Rutong
    Gao, Shangfeng
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (03) : 1339 - 1348
  • [10] β-HCG、ERK1/2及MMP-2在卵巢癌中的表达及意义
    耿欣
    刘彦芳
    高玉梅
    郭晓青
    广东医学, 2015, 36 (09) : 1371 - 1374